IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $7,500 | +6.7% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $7,028 | +11.1% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,328 | +13.7% | 150 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $5,567 | -0.2% | 150 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $5,579 | -7.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | +20.0% | 150 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $5,000 | -16.7% | 150 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $6,000 | -14.3% | 150 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $7,000 | -22.2% | 150 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $9,000 | +28.6% | 150 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $7,000 | -22.2% | 150 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $9,000 | +12.5% | 150 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $8,000 | -11.1% | 150 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $9,000 | – | 150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |